Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of Telmisartan/S-Amlodipine in Hypertension
NCT02526875Phase 4Unknown
- Sponsor
- Chong Kun Dang Holdings
- Start
- Apr 2015
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of telmisartan, Levamlodipine in hypertension (HTN), sponsored by Chong Kun Dang Holdings. Status: unknown.
02
Drugs
telmisartanLevamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02526875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02526875.